Patients were divided into two groups: high ACE2 expression and low ACE2 expression. The survival analysis was analyzed using a Kaplan-Meier plot. No significant difference was observed in overall survival between the two expression level groups, but it was observed that patients with READ and STAD had more favorable outcomes in the high ACE2 expression group than the low expression group.

• COAD: colon adenocarcinoma
• KIRP: kidney renal papillary cell carcinoma
• PAAD: pancreatic adenocarcinoma
• READ: rectum adenocarcinoma
• STAD: stomach adenocarcinoma
• KICH: kidney chromophobe
• SARC: sarcoma
• TGCT: testicular germ cell tumors
• THCA: thyroid carcinoma